Skip to content

Use of three ring vulvoscopy in patients with vulval disease

Determination of clinical utility of Three ring vulvoscopy (TRIV) for detection of vulval pathologies

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/063215
Enrollment
54
Registered
2024-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R876- Abnormal cytological findings in specimens from female genital organs Health Condition 2: N90- Other noninflammatory disorders ofvulva and perineum

Interventions

Intervention1: three ring vulvoscopy: Symptomatic women with any vulval symptoms (chronic or recurrent vulval, visible vulval lesions, any abnormal skin changes or whitening or hardening of the vulvar

Sponsors

post graduate institute of medical education and research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: age more than 18 years women with any vulval complaints women with abnormal findings on routine examination women diagnosed with HSIL

Exclusion criteria

Exclusion criteria: antennal woman active malignancy under chemoradiation post chemo radiation active genital lesions

Design outcomes

Primary

MeasureTime frame
To compare the TRIV for diagnosis of various vulval pathologies in different study groups with unaided examinationTimepoint: To compare the TRIV for diagnosis of various vulval pathologies in different study groups with unaided examination

Secondary

MeasureTime frame
to find best biopsy location with TRIV in woman with abnormal vulval findingsTimepoint: at same time during vulvoscopy same day;to find prevalence of various vulval pathologies in different study groupTimepoint: After completion of study, i.e. after 1 year

Countries

India

Contacts

Public ContactDr. Bharti Joshi

post graduate institute of medical education and research

drbhartijoshi09@gmail.com9915166210

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026